Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Citicoline wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
3 of 5 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (2)
Outcomes where both Citicoline and Noopept have evidence — compare verdict strength side-by-side.
250-500mg daily
Morning for daytime cognitive enhancement
Cognizin® branded citicoline
10-30mg daily in divided doses
Morning and early afternoon, Divided into 2-3 doses, Sublingual for faster onset
Noopept powder (sublingual) or capsules
1-4 weeks
4-8 weeks
1-2 weeks
1-2 weeks
Acute to 1 week
Ongoing
With higher doses
Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis
Nutrients (2023) · Meta analysis
Overall, citicoline improved cognitive status, with pooled standardized mean differences ranging from 0.56 (95% CI: 0.37-0.75) to 1.57 (95% CI: 0.77-2.37) in different sensitivity analyses.
Application of Citicoline in Neurological Disorders: A Systematic Review
Nutrients (2020) · Systematic review
In an animal model of nerve damage and neuropathy, citicoline stimulated regeneration and lessened pain.
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly
Cochrane Database of Systematic Reviews (2005) · Systematic review
Positive effects on memory
Novel Technologies for Dipeptide Drugs Design and their Implantation
Current pharmaceutical design (2018) · Systematic review
The latter usually corresponds to a beta-turn of some regulatory peptide.
Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation
Journal of biomedical science (2014) · Observational
Taken together, these data provide evidence that novel cognitive enhancer noopept protects PC12 cell against deleterious actions of Aβ through inhibiting the oxidative damage and calcium overload as well as suppressing the mitochondrial apoptotic pathway.
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin
Neuroscience and behavioral physiology (2009) · Observational
Clinical trial examining Noopept efficacy
Based on meta-analysis showing SMD 0.56-1.57 for cognitive status improvement. Conservative estimates due to heterogeneity across studies and varying populations (stroke, dementia, TBI). Effect sizes modest and studies show mixed quality levels.
Based on RCT with n=60 showing MMSE improvements after 2 months. Most studies lack placebo controls and have small sample sizes. Effectiveness may be overestimated due to study limitations.
AI-estimated from published studies. Interpret as directional guidance.
Citicoline has a higher evidence score (6/10 vs 4/10) and wins in 3 of 3 categories.
For sharpen focus, Citicoline has a higher relevance score (88 vs 75).
No known interactions between Citicoline and Noopept have been documented in our database. However, always consult a healthcare provider before combining supplements.